Wake up to changed EU regulatory environment, Eucomed tells medtech
This article was originally published in SRA
Executive Summary
The EU medtech environment today is a different place in which to do business compared with just a year ago. John Brennan of Eucomed told Amanda Maxwell how the medical device industry is approaching the next phase of dialog with the new decision-makers in Europe, what its priorities are, and how companies should be positioning themselves to cope with new expectations.